Citi downgrades Human Genome Sciences Inc (Nasdaq: HGSI) from Buy to Hold. Price target lowered from $10 to $8.
This article: 148 words
-->

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE